🇺🇸 FDA
Patent

US 7790899

Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms

granted A61PA61P25/06A61P25/14

Quick answer

US patent 7790899 (Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms) held by ACADIA Pharmaceuticals Inc. expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ACADIA Pharmaceuticals Inc.
Grant date
Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P25/06, A61P25/14, A61P25/16, A61P25/18